Shares of Moderna MRNA were up 15.8% on Jan. 21, after the company and its partner Merck MRK announced positive median ...

Moderna’s (MRNA) mRNA-based cancer therapy, intismeran autogene (mRNA-4157), with Merck’s (MRK) anti-PD-1 therapy, Keytruda, ...

mRNA-3927 is an investigational novel mRNA-based therapeutic agent that is composed of two mRNAs encoding for normal human ...

The companies have an expansive clinical program for the mRNA neoantigen therapy intismeran autogene in combination with ...

Researchers developed cSMRTS, an engineered mRNA that preferentially turns on therapeutic genes inside targeted cells, shown in mice, enabling safer, more precise treatments. (Nanowerk News) ...

Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine—which designs nanotechnology-based platforms for clinical translation across specialties—developed a strategy ...

There's a potential new method to treat infertility through mRNA technology, according to Johns Hopkins Medicine research. In ...

There's a potential new method to treat infertility through mRNA technology, according to Johns Hopkins Medicine research. In what could be a step forward for endometriosis patients, the method that ...

Nitin Joshi, PhD, and Jingjing Gao, PhD, of the Department of Anesthesiology at Mass General Brigham, are the co-senior authors of a paper published in Nature Nanotechnology, "A ...